An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis
Public ClinicalTrials.gov record NCT03777436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double Blind-Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase 3 multicenter, randomized, placebo-controlled, double-blind study is designed to evaluate the efficacy and safety of apremilast in subjects with moderate to severe genital psoriasis (modified sPGA-G ≥3, moderate or severe). Approximately 286 subjects with moderate to severe genital psoriasis will be randomized 1:1 to receive either apremilast 30 mg BID or placebo for the first 16 weeks.
Study identification
- NCT ID
- NCT03777436
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 289 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 11, 2019 (Actual)
- Primary completion
- Sep 23, 2021 (Actual)
- Completion
- Feb 9, 2022 (Actual)
- Last update posted
- May 14, 2024
2019 – 2022
United States locations
- U.S. sites
- 26
- U.S. states
- 19
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Glick Skin Institute | Margate | Florida | 33073 | — |
| International Dermatology Research, Inc | Miami | Florida | 33144 | — |
| Skin Care Physicians of Georgia | Macon | Georgia | 31217 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| Adult and Pediatric Dermatology | Overland Park | Kansas | 66211 | — |
| ActivMed Practices and Research Inc | Beverly | Massachusetts | 01915 | — |
| Brigham and Womens Hospital | Boston | Massachusetts | 02115 | — |
| J Woodson Dermatology and Associates | Henderson | Nevada | 89052 | — |
| Las Vegas Dermatology | Las Vegas | Nevada | 89144 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03766 | — |
| ActivMed | Portsmouth | New Hampshire | 03801 | — |
| Stony Brook Dermatology Associates | Stony Brook | New York | 11790 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Oakview Dermatology | Athens | Ohio | 45701 | — |
| Ohio State University Medical Center | Gahanna | Ohio | 43230 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Paddington Testing Company Inc | Philadelphia | Pennsylvania | 19103 | — |
| Clinical Partners LLC | Johnston | Rhode Island | 02919 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | — |
| Virginia Clinical Research Inc | Norfolk | Virginia | 23502 | — |
| Bellevue Dermatology Clinic | Bellevue | Washington | 98004 | — |
| Dermatology Center for Skin Health | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03777436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2024 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03777436 live on ClinicalTrials.gov.